MR
Michael Ryskin BofA Securities Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
9
Avg Return
Past Year
Past Year
16%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Buy
22.2%
Hold
66.7%
Sell
11.1%
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
Revvity
RVTY
$10.2B
|
Buy
Maintained
| $99 |
12%
upside
| 1 | +1.8% |
0
%
| 22 Sep ‘25 20 days ago |
|
|
TEM
Tempus AI
TEM
$16.7B
|
Hold
Maintained
| $70 |
27%
downside
| 4 | – |
–
| 25 Jun ‘25 3 months ago |
|
Idexx Laboratories
IDXX
$49.3B
|
Hold
Maintained
| $475 |
23%
downside
| 2 | – |
–
| 21 Apr ‘25 5 months ago |
|
Maravai LifeSciences
MRVI
$462M
|
Buy
Maintained
| $8 |
151%
upside
| 1 | -0.93% |
0
%
| 3 Mar ‘25 7 months ago |
|
Align Technology
ALGN
$9.12B
|
Sell
Maintained
| $206 |
64%
upside
| 1 | +47% |
0
%
| 13 Dec ‘24 10 months ago |
|